AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
QXO
ACCE-researched

QXO Inc. Common Stock (QXO) fair value

Industrials · Industrial Distribution · NYSE · United States
$10.51-4.63%
Market cap $11.4BNext earnings 2026-11-05Updated Oct 20, 2026
Add earnings to calendarGoogle
Our verdict
Trades 101% above our fair value
Price
$10.51
Model fair valueConfidence: good
$5.22
Model range
$4.68 to $5.67
Fair value $5.22
Price $10.51
2 models fit QXO Inc. Common Stock and they agree: 2 of 2 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)
Valued as a growth company: Discounted cash flow, P/E comparison, and EV/EBITDA comparison.
ACCE opinionQXO Inc. Common Stock (QXO)
Fair value (2 models)
$5.22
ACCE price target
$12.00
Rating
Overvalued
Horizon
12 months
Fair value published on 20 Oct 2026, 14:06 CEST; previously $4.64 since 16 Oct 2026, 00:00 CEST.
ACCE price target published on 26 Sept 2026, 00:00 CEST.
Rating published on 20 Oct 2026, 14:06 CEST.
Price used: $10.51 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
101.4% above
-50.3% to fair value
ACCE score
38
out of 100
Analysts
100% buy
19 covering
P/E
0.0x
forward 19.2x
1-year return
-42.6%
Dividend yield
0.00%

QXO Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

QXO distributes building products, and it is pursuing an aggressive acquisition strategy to consolidate a fragmented market, which explains the 70.3% revenue growth. The bull case rests on that roll-up: a larger, more diversified distribution platform could earn better purchasing terms and cross-sell into more end markets over time. Current profitability is thin, with a 24.5% gross margin, a 1.3% operating margin and negative return on equity of -4.6%, so the thesis depends on integration delivering margin expansion rather than on the business as it stands today. At a forward P/E of 19.1 on an 11.4B market cap, the stock is pricing in that earnings recovery, and the score of 38/100 suggests the screen does not yet see enough evidence to support it. The name merits a deeper look mainly to test whether acquired revenue is converting into operating income, and to establish what the forward estimates assume.

AI-assisted·How I use AIWritten Oct 14, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • high
    Earnings growth stalled
    Revenue surged 70% YoY but earnings grew 0%, signalling margin collapse. Net margin is negative at -5.2% despite 24.5% gross margin.
  • high
    Valuation stretched on deteriorating quality
    EV/EBITDA 40.6x and forward P/E 19.2x with negative ROE (-4.6%) and ACCE Quality score only 31/100. No earnings support for multiple.
  • moderate
    Short interest elevated
    12.8% short float is material. Combined with negative profitability and stalled earnings, suggests market scepticism is warranted.

AI research notes

AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Revenue has grown 70.3% year over year with a 5-year average of 178.0% annually, showing exceptional top-line momentum.
  • The company generated $183M in free cash flow over the last 12 months while maintaining a conservative 0.40 debt to equity ratio.
Why it could disappoint
  • Net margin is negative at -5.2% and ROE is -4.6%, showing the company is not yet profitable on earnings or capital.
  • Share count surged 50.2% in the last fiscal year, diluting existing shareholders significantly as the company funds growth.
  • At a forward P/E of 19.2x and free cash flow yield of only 1.6%, the stock is priced for perfection with limited margin of safety.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 5, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where QXO's valuation models land
Price
$10.51
Model fair value
$5.22
Model range
$4.68 to $5.67
Fair value $5.22
Price $10.51
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish100% buy · 19 covering analysts
● Strong buy 15● Buy 4● Hold 0● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-3.2%
1 month
-14.4%
3 months
-23.1%
6 months
-49.9%
YTD
-45.5%
1 year
-42.6%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
20 Oct 2026, 14:06 CESTFair value$5.22$4.64$10.14
20 Oct 2026, 14:06 CESTRatingOvervaluedfirst publication$10.14
16 Oct 2026, 00:00 CESTFair value$4.64$4.75$10.33
15 Oct 2026, 00:00 CESTFair value$4.75$3.75$11.02
5 Oct 2026, 00:00 CESTFair value$3.75$3.70$12.06
1 Oct 2026, 00:00 CESTFair value$3.70$3.76$11.62
28 Sept 2026, 00:00 CESTFair value$3.76$4.23$12.43
26 Sept 2026, 00:00 CESTACCE price target$12.00first publication$12.43
26 Sept 2026, 00:00 CESTFair value$4.23$3.92$12.26
24 Sept 2026, 00:00 CESTFair value$3.92$3.86$12.78

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full QXO page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth64Value38Quality31Momentum17Total38
Valuation
Trailing P/E
0.0x
Forward P/E
19.2x
PEG
0.96
P/B
1.37x
EV / Revenue
1.8x
Book value/sh
$12.85
Enterprise value
$18.1B
Profitability
ROE
-4.6%
FCF yield
1.71%
ROIC
-1.7%
Health and risk
Debt / equity
0.40
Dividend yield
0.00%
Beta
2.28

Price

-42.8% · 1Y

Ask anything about QXO

Answered from QXO Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 0.0x0.0xhigh 50.7x
ROEbetter than 0% of peers
low -5%-5%high 22%
Div yieldbetter than 17% of peers
low 0.0%0.0%high 4.0%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
QXO QXO Inc. Common Stock$10.51$5101% above--4.6%3138
TIH.TO Toromont Industries Ltd.C$202.40C$14144% above31.4x16.0%7258
AIT Applied Industrial Technologies Inc. Common Stock$319.40$19663% above30.9x22.4%7362
DPLM.L Diploma PLC£72.60£3890% above50.7x18.9%7761
WSO Watsco Inc. Common Stock$327.04$21652% above25.8x16.7%6842
INDT.ST Indutrade AB (publ)kr 258.60kr 16160% above33.6x15.7%6459
FTT.TO Finning International Inc.C$95.00C$6937% above23.1x19.3%5357

Sector report card

Where QXO ranks against its sector peers on each metric.

Computing percentiles…
  • GlobeNewswire•Sep 28, 2026
    Acocelli Law, PLLC and Long Law, LLC Announce Agreement to Resolve Claim for Attorneys’ Fees and Expenses in connection with Lawsuit Pending in the Delaware Court of Chancery captioned Thompson v. QXO, Inc., C.A. No. 2026-0757-BWD (Del. Ch.)
  • Business Wire•Aug 24, 2026
    QXO Appoints Ken West as President and Chief Operating Officer
  • Business Wire•Aug 13, 2026
    QXO Reports Second Quarter 2026 Results
2 more press releases · full archive on Investor+.INVESTOR
40 filings
October 2026
Oct 19
Form 4Insider transactionPeriod 2026-10-15
View on SEC →
Oct 13
Form 4Insider transactionPeriod 2026-10-08
View on SEC →
September 2026
Sep 17
Form 4Insider transactionPeriod 2026-09-15
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR